|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/30 | |
| A61K 38/29 | |||
| A61K 47/22 | |||
| A61K 47/20 | |||
| A61K 47/10 | |||
| A61K 38/48 | |||
| A61K 38/25 | |||
| A61K 38/16 | |||
| A61K 38/02 | |||
| A61K 38/18 | |||
| A61K 38/17 | |||
| A61K 38/09 | |||
| A61K 9/00 | |||
| A61K 38/28 | |||
| A61K 38/26 | |||
| A61K 38/22 | |||
| A61K 47/18 | |||
| A61K 47/14 | |||
| A61K 47/12 |
| (11) | Number of the document | 3225235 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17151475.5 |
| Date of filing the European patent application | 2012-03-09 | |
| (97) | Date of publication of the European application | 2017-10-04 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-16 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161451568 P | 2011-03-10 | US | |
| 201161478692 P | 2011-04-25 | US | |
| 201161553388 P | 2011-10-31 | US |
| (72) |
KINZELL, John, US
PRESTRELSKI, Steven, US
|
| (73) |
Xeris Pharmaceuticals, Inc.,
180 N. LaSalle Street, Suite 1600, Chicago, IL 60601,
US
|
| (54) | STABLE PEPTIDE FORMULATIONS FOR PARENTERAL INJECTION |
| STABLE PEPTIDE FORMULATIONS FOR PARENTERAL INJECTION |